Commercializing Tools for Biomedical Research - Innovation ...
Commercializing Tools for Biomedical Research - Innovation ... Commercializing Tools for Biomedical Research - Innovation ...
Commercializing Toolsfor Biomedical ResearchAlexander P. Ducruet, Ph.D.Senior Technology Licensing ManagerOffice of Technology ManagementUniversity of Pittsburgh© 2011 University of Pittsburgh – Office of Technology Management and Office of Enterprise Development
- Page 2 and 3: Outline• Introduction• Dissemin
- Page 4 and 5: Why Disseminate ResearchTools?• F
- Page 6 and 7: • TypesPublication• Peer-review
- Page 8 and 9: Establishing Ownership• Universit
- Page 10 and 11: © 2011 University of Pittsburgh -
- Page 12 and 13: • Exclusive LicenseLicense Types
- Page 14: Conclusions• Research Tools are u
<strong>Commercializing</strong> <strong>Tools</strong><strong>for</strong> <strong>Biomedical</strong> <strong>Research</strong>Alexander P. Ducruet, Ph.D.Senior Technology Licensing ManagerOffice of Technology ManagementUniversity of Pittsburgh© 2011 University of Pittsburgh – Office of Technology Management and Office of Enterprise Development
Outline• Introduction• Disseminating <strong>Research</strong> <strong>Tools</strong>• Commercialization strategies© 2011 University of Pittsburgh – Office of Technology Management and Office of Enterprise Development
What is a <strong>Research</strong> Tool?•<strong>Research</strong> <strong>Tools</strong> are unique resources developed whileconducting research that are necessary to per<strong>for</strong>m furtherstudies• For Example:• Monoclonal Antibody (e.g.hybridoma)• Polyclonal Antibody (e.g. asycites orpurified antibody)• Cell lines• Cell products• Transgenic animals• Organisms• Synthetic compounds• Cloned DNA• DNA sequences• Peptides• Viral Vectors• Mapping in<strong>for</strong>mation• Medium• Crystallographic coordinates• Spectroscopic data© 2011 University of Pittsburgh – Office of Technology Management and Office of Enterprise Development
Why Disseminate <strong>Research</strong><strong>Tools</strong>?• Facilitates the progress of biomedicalresearch• Promotes cooperation and collaborations• Academic and non-academic• Complies with NIH policy and processesencouraging exchange of materialsdeveloped with federal funds© 2011 University of Pittsburgh – Office of Technology Management and Office of Enterprise Development
Dissemination of <strong>Research</strong> <strong>Tools</strong>• Publication• Timely disclosure• Transfer of material• Academic• Non-Academic• Determination of ownership• Invention Disclosure Determining patentability• Establishing Ownership© 2011 University of Pittsburgh – Office of Technology Management and Office of Enterprise Development5
• TypesPublication• Peer-reviewed manuscripts,presentations, scientific meetings• Facilitates the dissemination• Reasonable delays in publications• Ensure confidential in<strong>for</strong>mation <strong>for</strong> patent filing• Certain agreements allow a third party reasonabletime to review data to determine patentability Sponsored <strong>Research</strong> Agreement Material Transfer Agreement© 2011 University of Pittsburgh – Office of Technology Management and Office of Enterprise Development6
Transferring the Material• Academic Request• Contact the Office of <strong>Research</strong> (OOR) MTA submission <strong>for</strong>m (http://www.pitt.edu/~offres/mta.html)• Biological Resource Center• Examples: ATCC,Jackson Laboratory• Contact OOR• OOR and Office of Technology Management (OTM)will review the distribution policy of center Limit distribution to academic parties only• Non-Academic Request• License agreement to access material• Contact OTM© 2011 University of Pittsburgh – Office of Technology Management and Office of Enterprise Development7
Establishing Ownership• University policies• Federal funding• Bayh-Dole Act Ownership reverts to grantrecipient’s institute• Non-federal funding• Grant award must be reviewed to determine ownership• Corporate Sponsored <strong>Research</strong> Agreement OTM and OOR review agreement terms• Third party materialsInstitutionGInstitutionFInstitutionEInstitutionAInstitutionD• OOR and OTM work with investigator(s) to relevant agreements(e.g. MTA)InstitutionBInstitutionC© 2011 University of Pittsburgh – Office of Technology Management and Office of Enterprise Development8
Patenting <strong>Research</strong> <strong>Tools</strong>• Patentable if new, useful, and non-obvious• <strong>Research</strong> tools are typically not patented• Costs associated with the patent process• Exclusivity not necessary in research market• Some research tools are patented if they have broador therapeutic applications• Cre-lox system• GFP• Monoclonal antibodies• Viral vectors© 2011 University of Pittsburgh – Office of Technology Management and Office of Enterprise Development9
© 2011 University of Pittsburgh – Office of Technology Management and Office of Enterprise Development10
Commercialization Strategy• How does a company want to use it?• Sell your material as a research tool to theresearch market Non-exclusive vs. Exclusive license Example: Antibodies, Transfection Reagents, etc.• Use your material <strong>for</strong> internal research Biomaterial <strong>Research</strong> License– Similar to non-exclusive– Limited scope and term Example: drug development© 2011 University of Pittsburgh – Office of Technology Management and Office of Enterprise Development11
• Exclusive LicenseLicense Types• One company allowed to develop and/or distribute yourmaterial You retain the rights to use the material <strong>for</strong> internal research use andto distribute to your colleagues and other non-profits• Due Diligence Milestones Licensee must develop the material– Payment associated with achievement of milestones• If appropriate, licensee must pay <strong>for</strong> patent expenses• Non-Exclusive License• Materials can be licensed tomultiple companies• No due diligence milestones© 2011 University of Pittsburgh – Office of Technology Management and Office of Enterprise Development
• 2000-2010<strong>Research</strong> Tool Licensing• <strong>Research</strong> Tool Licenses: 37• Total Revenue Generated: $1.43M• Revenue to Innovators: $643,500© 2011 University of Pittsburgh – Office of Technology Management and Office of Enterprise Development13
Conclusions• <strong>Research</strong> <strong>Tools</strong> are unique resources that enableinnovation• Distribution of <strong>Research</strong> <strong>Tools</strong> is stronglyencouraged• <strong>Commercializing</strong> <strong>Research</strong> <strong>Tools</strong>• Broadly enables innovation• Eases burden of distribution• Generates revenue• Talk to OTM to learn more about <strong>Research</strong> <strong>Tools</strong>http://www.otm.pitt.edu/© 2011 University of Pittsburgh – Office of Technology Management and Office of Enterprise Development14